Healthcare Businesses for Sale and Investment in Romania

The company is the national market leader in professional podology in Romania, operating within a category that has emerged only within the past decade. Leadership was established in its first year by surpassing the annual revenue of a long-standing incumbent, highlighting both strong execution and an early-mover advantage. The market remains structurally underpenetrated, with less than 15% of the addressable population currently accessing podology services, compared to 40–60% in Western Europe, implying a 3–5x organic growth runway independent of market share gains. The business serves a base of over 5,100 active patients, generating approximately 19,300 visits annually (~1,600 per month), with consistently high satisfaction levels—over 95% of clients rate their experience 5/5 based on a large internal survey sample. The revenue model is centered on in-clinic medical services with strong recurrence dynamics, as chronic conditions typically require follow-up visits every 4–8 weeks. Unit economics are well validated, with a 24-month patient lifetime value of approximately 1,150 RON against a fully loaded customer acquisition cost of 132 RON, resulting in a rapid payback period of roughly three weeks. A core pillar of the investment case is the significant operating leverage embedded in the current setup. The flagship clinic is built to support approximately 3,200 visits per month but is currently operating at around 50% utilization. With fixed costs such as lease, equipment, and baseline staffing already covered, incremental revenue flows at an estimated ~80% contribution margin. As a result, increasing utilization toward capacity can drive EBITDA margins from approximately 12% to 25%+ without additional capital expenditure. The company generates approximately EUR 1.2 million in annual revenue, with gross margins around 60% and EBITDA margins of 12% at current utilization (normalized for founder compensation). The business is debt-free, with no external bank financing, and operates under a clean single-shareholder structure. A key competitive moat is its in-house training academy, which addresses a critical talent bottleneck in the Romanian podology market. While traditional pedicurists often resist formal employment structures, the company recruits medically trained assistants and upskills them into certified podology technicians through its proprietary curriculum. This creates a scalable and defensible talent pipeline, reduces dependency on the external labor market, generates an additional revenue stream through training, and establishes a meaningful barrier to entry for competitors. Additional defensibility is reinforced through proprietary clinical protocols (including comprehensive treatment frameworks), standardized operating procedures across all services, a robust and growing patient database with full clinical histories, and a proven marketing infrastructure. Operations are supported by a team of approximately 30 clinical and administrative staff, with processes sufficiently systematized to run independently of daily founder involvement. The founder brings over a decade of entrepreneurial and operational experience across multiple markets and is supported by a capable senior team spanning operations, marketing, and technology. Key person risk is actively mitigated through documented processes, the internal talent pipeline, and planned leadership expansion, including the addition of a COO to support multi-site scaling. Over time, the founder is expected to transition toward a strategic leadership role as the network expands. The business is fully compliant from a regulatory standpoint, operating as a licensed medical entity with all required authorizations in place. With a proven single-location model, strong unit economics, and a ready talent pipeline, the company is now operationally prepared to expand into multiple locations, with the first satellite clinic already in development and a clear blueprint for replication.

Profitable importer and distributor of equipment, devices, and consumables for surgery and aesthetic dermatology. - Product portfolio includes lasers, breast implants, fillers, collagen, PRP kits, and 700+ consumables and accessories. - Partners with leading international suppliers from France, Italy, Spain, Germany, and the USA. - Distribution across Romania and other EU countries via in-house sales team and online channels. - Market leader in Romania with ~30% share and a client base of 1,400+ corporate customers. - Offers weekly training courses, seminars, and conferences for doctors, strengthening brand reputation. - Provides specialized service and maintenance for advanced medical equipment. - Strong workforce of highly trained staff operating under excellent working conditions. - Operates with a flexible team structure, hiring contractual employees as needed. - The business operates with a valid operations license.

Introducing a new Italian line Âge De Rêve®. Crafted with meticulous care in Italy, our skincare line embodies quality efficacy, and innovation backed by science. - Our products stand out for their well-researched ingredients, including three patented compounds that have been proven to effectively combat fine lines, wrinkles, while simultaneously enhancing skin firmness and radiance. - With Âge De Rêve®, customers can expect premium quality and visible results. - We believe in fostering long-term partnerships, which is why we offer competitive price brackets for the various batch sizes that are as low as 200 units per item and provide distributors with post-sales services. This includes monthly packages of social media content and marketing strategies, designed to help promote Âge De Rêve® effectively and drive sales in their target market. - The products are yet to be launched in the market. Channel of sales will be through distributors and the official website. - Planning to launch in 2-3 months. - The sales figures and profit margins mentioned are based on projections.

Company and product: Enbiosis has developed an advanced artificial intelligence algorithm that analyzes the human gut microbiome and recommends personalized food and supplements to individuals to improve their gut health and address chronic disorders such as gastrointestinal disorders, skin-related disorders, and weight loss issues. - How it works: Patients/customers send their stool samples to any NGS laboratory in their region. Enbiosis takes the raw bacterial DNA data to the local server (to avoid data protection risks) and creates a personalized report, which is sent to patients and, if required, their practitioners within minutes. - Business model: Enbiosis's microbiome test can be sold through practitioners and/or directly to customers, depending on market dynamics. Practitioners can prescribe the test to patients to generate a personalized diet plan, or patients can follow their personalized nutrition guide through the app to improve general well-being and solve their problems. - Main differentiation: Enbiosis is the only clinically proven precision diet technology that claims to address the main cause of chronic disorders. It has conducted three clinical trials and published the results in peer-reviewed journals. Enbiosis's claims are backed by scientific evidence. - The main reason why investors should consider Enbiosis: In recent years, the number of people seeking to address their health problems through alternative methods instead of pharmaceuticals has been increasing. The challenge in alternative medicine is the lack of scientific data. Enbiosis serves as a bridge between alternative medicine and conventional medicine, and there is significant market potential for Enbiosis. For example, Enbiosis has proven the effectiveness of its technology in patients with IBS, who make up about 10% of the population. Offering individuals the opportunity to solve their chronic problems simply by changing their diet within a specific period is something they are interested in and willing to try. - Additionally, investors/distributors can offer a routine follow-up program to check gut health and prevent any kind of diseases, opening the door to long-term recurring revenue. - We have a trade registration certificate to operate.

We develop new nanostructured surfaces with new functions for medical devices. - Our first application is the first dental implant covered with a layer of TiO2 nanotubes. We have patented production procedures, European Conformity, and ISO 13485 certification. - Production facility is located in Romania and meets the highest hygiene standards. - We have supplied our products to 150 doctors who use them regularly. - We have 2 vendors for our high-quality raw materials. - Company has recently signed a grant contract with the Romanian Research Ministry for our new unique nanotech products, worth EUR 3.3 million. - Current production capacity is 13,200 pieces per month. After starting the new project we will have a monthly production capacity of 33,000 pieces per month.

Pilates Room is a brand created based on the experience and success of YA. Fitness. We have created a unique space for comfortable and safe sports. In less than 2 years, we have firmly established the title of brand No. 1 in the field of women's fitness in Kazakhstan. The best designs and conditions, large-scale collaborations, and high guest loyalty helped us grow at a breakneck pace. We have 2 branches in Almaty, and the standards of the branches include the mandatory availability of shower cabins, personal hygiene products, equipment, modern air conditioning and ventilation systems, heated floors, high-quality equipment and qualified coaching staff. Brand trusted by millions of women. We invest tens of thousands of dollars in promotion, actively support large-scale events such as VISA Fashion Week and Miss Kazakhstan, cooperate with the best brands in the field of fashion, beauty and health, and more than 80 well-known influencers are friends of the brand. By opening a Pilates studio with our franchise, you become a pioneer in a market that is just beginning to develop. To be in trend while it is at the peak of its growth means to gain a competitive advantage and high profits. A strong brand, expert support, and the popularity of the destination make this one of the most promising investments in the fitness industry. The financial estimates given for our franchise formats are based on our existing outlets and may vary depending on the location.

This distributor opportunity is available globally, with strong worldwide demand. The partner does not have to be physically located in countries that you want to sell to. Your sales reach is not limited to the United States or any specific country. Distributors are needed worldwide. The initial investment starts at only $1,800 for a new demonstration unit. Operations can be managed remotely or from an existing business location. The Vein-Eye Carry is the only vein illumination device on the front lines in both Ukraine and the Mddle East, helping to save the lives of soldiers and civilians who have been severely injured. Our company is partially owned by the City University of New York and the Department of Energy. We have designed, engineered, and manufactured the premier vein finder on the market. The growth of diabetes, obesity, cardiovascular diseases, cancer, and inflammatory diseases are the leading causes of death, making it nearly impossible to locate veins in affected individuals. The Vein-Eye Carry is registered with the FDA, has the CE Mark, and has been certified safe by Intertek and UL. It is the only medical device capable of penetrating very dark skin, layers of fat, and human hair. We have never encountered a patient where we could not find a vein. Weighing around 4 lbs. , it is lightweight, portable, and can be placed in an ambulance or used in home healthcare settings. Additionally, it is being sold to surgeons to help them detect bleeding in tissue post-surgery.

In 2015, a group of young masters in optical design, coating, polishing, and analysis came together to found our company. We initially entered the optical medical device market with the IDS-1100 dermatoscopy, a skin diagnostic device developed through extensive research, analysis, and numerous trials and errors. Since our founding, ILLUCO has been dedicated to constantly developing new products and enhancing existing ones. With support from the Korean government, recognizing our technological expertise, we have been able to invest boldly in product development and upgrades. As a result, we successfully developed and marketed the IDS-Series product line. We are committed to creating products that our customers find valuable and providing a comprehensive "one-stop service system" that includes design, manufacturing, assembly, quality control, and testing. Our goal is to deliver the highest value to our customers. In the field of optics, we pay special attention to every detail, from design to quality testing and mass production, ensuring we meet our customers' needs. Working with "craftsmanship in mind" is our top priority and our key to thriving and making a name in the market. The company holds the following licenses: CEMDR and ISO 13485.

Lymphacare is number 1 in selling and renting lymphatic massage devices in Israel. - We found new selling opportunities and developed new markets for devices we exclusively importing. - Proven to be effective in treating problems in the lymphatic system accompanied by pain, edema and swelling as a result of chronic disease, injury or surgery (including orthopedic and cosmetic surgeries), vascular diseases and oncology. - Business model is both B2B, which is by supplying to professionals and B2C is by directly supplying to customers. - The sales channels are offline. - The selling price, rent prices and the financials will be disclosed later. - Devices are imported from a reputed manufacturer. - Business has FDA approval. - Only a one-time brand fee will charged. No additional commission on monthly sales will be charged. The brand will profit through the monthly supply of the devices to the dealer. Why Invest in Our Franchise? ✅ Proven Demand – The health and wellness industry is growing rapidly, with increasing awareness of lymphatic health and its benefits. ✅ Exclusive Territory – Secure your region and be the go-to distributor in your area. ✅ High-Profit Potential – Attractive margins and recurring revenue from a growing customer base. ✅ Comprehensive Training & Support – Get expert training on product knowledge, sales, and marketing strategies. ✅ Wide Customer Base – Perfect for wellness centers, spas, rehabilitation clinics, sports recovery facilities, and medical professionals. Why Partner with Us? ✔ High-Demand Market – Growing awareness of lymphatic health among wellness centers, medical professionals, and fitness experts. ✔ Exclusive Franchise Rights – Secure a dedicated territory with no competition from within our network. ✔ Proven & Innovative Product – Non-invasive, clinically backed devices used for detox, circulation improvement, and post-surgery recovery. ✔ Strong Profit Margins – Attractive returns with scalable growth potential. ✔ Complete Business Support – Comprehensive training, marketing assistance, and ongoing operational guidance.

We are a fashion designing firm from Israel and specialize in modern modest and stylish women's fashion and beauty. - Our business has been operational for the past two years and is in a growth phase with a lot of future potential. We are the creators of the best looking and quality press on nails. Our vision is to make all women in the world to stop wasting their time, money and health in a saloon without sacrificing the quality gel nail look. Our gel nails are reusable and come with our exclusive glue remover so that women of all ages can play around with their outfits and mix and match nails with their fashion. We see our nails being sold and loved by women all over the world. - We wish to connect with like-minded people who have the same vision as ours and want to work together with them. - The sales and profit margin are achievable.

UK's biggest exporter of plant-based skincare and supplements. - New stem cell innovation for cancer scars. - Fastest growing sector of skin care. - We are a group of scientists and plastic surgeons formulating according to the latest medical research. - We have recently launched our new product which is stem cell innovation for cancer scars. - Business won't be charging any brand fees or royalties as our main focus is to grow globally. - Monthly sales will depend upon our distributor partner and how much he/she is able to sell. - The franchise formats mentioned are estimated figures based on the already existing revenue of the business. - We request you to visit our website and check the awards our product has received.